Transaction in Own Shares

BAGSVAERD, DENMARK, Jul 13 (MARKET WIRE) --
On 29 January 2009, Novo Nordisk initiated its share repurchase programme
in accordance with the provisions of the European Commission's regulation
no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour
rules.

Under the programme Novo Nordisk will repurchase B shares for an amount
up to DKK 3.0 billion in the period from 29 January 2009 to 5 August 2009.

Since the announcement as of 6 July 2009, the following transactions have
been made under the programme:

Number of Average Transaction
shares purchase price value, DKK
Accumulated, last
announcement 8,759,682 2,429,210,357
6 July 2009 75,000 289.3600 21,702,000
7 July 2009 75,000 291.0200 21,826,500
8 July 2009 75,000 292.3400 21,925,500
9 July 2009 80,000 289.5900 23,167,200
10 July 2009 75,000 284.9800 21,373,500
Accumulated under
the programme 9,139,682 2,539,205,057

With the transactions stated above, Novo Nordisk owns a total of
19,931,741 treasury shares, corresponding to 3.2% of the share capital.
The total amount of shares in the company is 620,000,000 including
treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care.
In addition, Novo Nordisk has a leading position within areas such as
haemostasis management, growth hormone therapy and hormone replacement
therapy. Novo Nordisk manufactures and markets pharmaceutical products
and services that make a significant difference to patients, the medical
profession and society. With headquarters in Denmark, Novo Nordisk
employs more than 27,900 employees in 81 countries, and markets its
products in 179 countries. Novo Nordisk's B shares are listed on the
stock exchanges in Copenhagen and London. Its ADRs are listed on the New
York Stock Exchange under the symbol 'NVO'. For more information,
visit
novonordisk.com.

Further information:

Media: Investors:

Outside North America: Outside North America:
Elin K Hansen Mads Veggerby Lausten
Tel: (+45) 4442 3450 Tel: (+45) 4443 7919
ekh@novonordisk.com mlau@novonordisk.com

Kasper Roseeuw Poulsen
Tel: (+45) 4442 4471
krop@novonordisk.com

In North America: In North America:
Sean Clements Hans Rommer
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
secl@novonordisk.com hrmm@novonordisk.com

Company Announcement no 42 / 2009

This announcement was originally
distributed by Hugin. The issuer is solely responsible for the content
of this announcement.

Copyright Copyright Hugin AS 2009. All rights reserved.

Copyright 2009, Market Wire, All rights reserved.

-0-